Using immunological principles to inform malaria vaccine design

    Project: Research

    Project Details


    Malaria kills 420,000 people each year worldwide. While a vaccine does exist, efficacy is poor and protection wanes rapidly. We have made breakthroughs in understanding the immune response to malaria that allow us to design a new generation of malaria vaccines. Based on this we aim to generate a vaccine that induces sustained levels of high-quality antibodies targeting multiple targets on the parasite and so can provide sustained long-term protection.
    Effective start/end date1/04/2131/03/24


    • National Health and Medical Research Council (NHMRC): A$596,179.00


    Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.